We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Interest in targeted cancer therapies with fewer side effects has increased in recent years.
No takes yet. Share an insight, caveat, or question.
He et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: